Collective Competitive Intelligence & Landscape
collective.com ·
Overview
Collective Overview
The core mission of Research Collective is to humanize healthcare by reducing medical errors and enhancing patient safety through rigorous research and usability testing. Their target market includes top medical device manufacturers, pharmaceutical companies, biotech startups, and healthcare providers, aiming to create safer, more effective medical devices and healthcare solutions (Research Collective, Exa). The company's value proposition centers on leveraging human factors expertise to ensure medical products are not only safe but also easy to use and desirable, ultimately contributing to better patient outcomes and healthcare innovation.
Sources
Research Collective - Human factors research for the future of ...
research-collective.com
Research Collective - Human factors research for the future of medicine.
research-collective.com
We improve the interactions between people & their products.
research-collective.com
Research Collective | LinkedIn
linkedin.com
Research Collective - Contract Research Organization
researchcollective.io
Research Collective's Unforgettable 2024
research-collective.com
Research Collective
researchcollective.co
Collective Weekly Intel Updates
Receive weekly intel updates about Collective straight to your inbox.
Competitors
Collective Competitors
Dovetail specializes in market research and competitor analysis, providing tools for identifying and assessing direct competitors—those offering similar products or services targeting the same customer base (Dovetail). Its strength lies in detailed market analysis and templates that help businesses understand their competitive landscape. Unlike Collective, which might focus more on research collection, Dovetail emphasizes comprehensive market insights and strategic analysis.
Asana is a project management platform that also supports competitive analysis through its extensive features like workflows, automation, and goal tracking (Asana). While not a direct competitor in the intelligence space, it is used by organizations to manage competitive projects and strategic initiatives. Its market positioning is broader, targeting organizational productivity, and it compares to Collective by offering integration with various business functions rather than specialized competitive intelligence tools.
Simon-Kucher provides advanced strategic consulting with a focus on competitive analysis, market positioning, and pricing strategies. Their approach involves partnering with external experts to leverage sophisticated methodologies like SWOT analysis to identify market gaps and threats (Simon-Kucher). They are more consultative and strategic compared to Collective’s tech-driven approach, targeting larger enterprises seeking deep market insights and strategic planning.
Sources
Advanced strategies for effective competitive analysis - Simon-Kucher
simon-kucher.com
Direct vs. Indirect Competitors (6 Real-World Examples) - Klue
klue.com
Understanding Different Types of Competitors: Direct and Indirect ...
launchnotes.com
Find your competitors: direct vs. indirect competition - Dovetail
dovetail.com
Conduct a Competitive Analysis (With Examples) [2026] - Asana
asana.com
How to Conduct a Competitive Analysis - BDC
bdc.ca
User Research Platform Comparison: Top Platforms in 2026 | CleverX Blog
cleverx.com
Best Dovetail Alternatives and Competitors in 2026 for Centralized Research Insights | UXtweak
blog.uxtweak.com
Product & Pricing
Collective Product and Pricing Intelligence
Maze, a platform focused on user research and product testing, offers multiple plans, including an Enterprise tier that provides all features, with pricing details available upon request (Maze).
Elicit, an AI-powered research assistant, has a tiered pricing model ranging from a free plan to paid options costing up to $79 per user/month, with additional costs depending on contract length and discounts (Elicit, CostBench). As of February 2026, Elicit’s costs are estimated between $120 and $780 per user/month, depending on the tier and features selected (CostBench).
Other tools like CB Insights and OpinionX offer custom or tiered pricing, often tailored to enterprise needs, with CB Insights focusing on high-stakes decision-making for Fortune 500 companies (CB Insights) and OpinionX providing flexible plans for market research, including free options and premium enterprise solutions (OpinionX). The pricing landscape indicates a trend toward customized enterprise solutions with scalable features, automated reports, and extensive data access, with free tiers available for entry-level or casual users.
Sources
Maze Pricing & Plans | Consolidate product research
maze.co
Pricing | Elicit: The AI Research Assistant
elicit.com
Elicit Pricing 2026: $120-$780/user/month | CostBench
costbench.com
Pricing - CB Insights
cbinsights.com
Pricing Plans // OpinionX — Free Stack Ranking Surveys
opinionx.co
Pricing | Market Intelligence API Plans
markets.apistemic.com
Ad Campaigns
Collective Ad Campaigns
See the live ads Collective is running across Google, Meta, and LinkedIn — the creative, messaging, and platforms behind every campaign, updated automatically by ForesightIQ.
See of Collective's ads
Browse the live creative across Google, Meta & LinkedIn in the ad library
Hiring & Layoffs
Collective Hiring and Layoffs
OpenAI is notably planning to nearly double its workforce to 8,000 employees by the end of 2026, aiming to strengthen its position in the AI market and expand into enterprise solutions (onmsft). This aggressive hiring spree contrasts with broader industry layoffs, highlighting OpenAI's focus on growth and innovation despite economic pressures (thenews). The company is recruiting across key areas such as product development, research, engineering, and sales, indicating a strategic emphasis on enterprise adoption and competitive positioning (fortune).
In contrast, other tech firms like Atlassian have announced significant layoffs, reducing their workforce by approximately 10% (around 1,600 jobs) to fund further investment in AI and improve financial resilience (thenextweb). These layoffs reflect a strategic realignment, focusing on efficiency and AI-driven growth, even as the industry faces a 'SaaSpocalypse' driven by investor fears and sector-wide stock declines (atlassian). Overall, the hiring patterns signal a company strategy centered on AI innovation and enterprise expansion, while layoffs are often a response to market pressures and a need for operational efficiency (bestpmjobs). This mixed landscape underscores a broader industry trend: firms are balancing aggressive AI-driven growth with cost management and strategic realignment.
Sources
OpenAI to hire 8,000 employees by 2026 to catch with Anthropic - OnMSFT
onmsft.com
From AI layoffs to hiring frenzy: OpenAI plans to double workforce by 2026
thenews.com.pk
OpenAI plans to almost double its headcount this year, FT says | Fortune
fortune.com
Atlassian is cutting 1,600 jobs and replacing its CTO
thenextweb.com
The 2026 AI Layoff Wave — Or Is It "AI-Washing"? What Every PM Needs to Know | PM Resources - Best PM Jobs
bestpmjobs.com
An important update on our team - Work Life by Atlassian
atlassian.com
Leadership
Collective Management and Leadership Team
Financials
Collective Financial Performance, Fundraising, M&A
In terms of fundraising, Collective has successfully closed multiple funding rounds, attracting a notable investor base, although specific recent rounds are not detailed in the available data (Tracxn). The company's valuation and funding history suggest it is a high-growth fintech and SaaS company, emphasizing its market relevance.
Regarding M&A activity, there is no publicly available recent information indicating acquisitions or mergers involving Collective as of March 2026. The company's financial indicators, including revenue and funding, demonstrate a healthy trajectory, but specific M&A transactions are not documented in the current sources.
Sources
Collective Revenue, Funding & Valuation
prospeo.io
13 Financial Performance Measures Managers Should Monitor
online.hbs.edu
Financial Performance: Definition, How It Works, and Example
investopedia.com
30 Financial Metrics and KPIs to Measure Success in 2025 - NetSuite
netsuite.com
Business Financial Performance Metrics and Analysis - Medium
medium.com
Financial Performance Metrics Every Investor Should Know - FINRA
finra.org
Collective - 2026 Funding Rounds & List of Investors - Tracxn
tracxn.com
The Collective - 2026 Funding Rounds & List of Investors - Tracxn
tracxn.com
Partnerships
Collective Partnerships, Clients and Vendors
Sources
Partners | Recollective
recollective.com
How Microsoft Scaled Qualitative Research with Recollective’s AI-Powered Platform | Recollective
recollective.com
GBK Collective + Qualtrics Partnership
qualtrics.com
research collaborative
researchcollaborative.org
Research Collective - Contract Research Organization
researchcollective.io
Home | Research Collaborative
researchcollaborative.com
Events
Collective Event Participations
Sources
Mighty Mini Research Collective Unconference at PINK, Stockport on 16th June, 2026
happeningnext.com
Datavid events and Webinars
datavid.com
Events and Webinars - Digital Science
digital-science.com
Research Exchange Gathering a Success | Landscape Architecture Foundation
lafoundation.org
GenAI Collective: NYC Research Roundtable · Luma
luma.com
Frequently Asked Questions
What does Collective's $121M in total funding relative to ~$62.5M in annual revenue suggest about investor expectations for the business?
Collective's funding-to-revenue ratio of roughly 2:1 — $121M raised against approximately $62.5M in annual revenue — points to investors pricing in meaningful future growth rather than current scale. With an estimated valuation of around $200M, the implied revenue multiple is modest by high-growth SaaS standards, suggesting the market views Collective as a credible but not yet breakout business. The key question for corp-dev teams is whether the company can expand revenue meaningfully before needing another capital raise.
Does Collective's financial profile — ~$62.5M revenue, ~$200M valuation, $121M raised — look more like a business approaching profitability or one still burning toward scale?
The available data doesn't include burn rate or EBITDA figures, so a definitive profitability read is not possible. However, the combination of $121M in total funding against $62.5M in revenue, with no recent M&A or new round documented as of March 2026, could indicate the company is managing spend carefully rather than aggressively reinvesting. The absence of a documented recent funding round may suggest either improving unit economics or a pause in growth investment — a distinction that would materially affect acquisition pricing.
What does Collective's core focus on human factors research for medical devices signal about its competitive moat versus generalist UX research firms?
Collective's specialization in human factors, regulatory compliance, and usability testing for medical devices — serving top medical device manufacturers, pharma companies, and biotech startups — creates a defensible niche that generalist UX or market research platforms cannot easily replicate. Regulatory expertise (e.g., FDA human factors guidance compliance) and lab rental services represent sticky, service-intensive offerings that commoditized SaaS tools like Maze or Dovetail are not designed to replace. A 21-person team serving this vertical signals intentional focus over scale, which limits total addressable market but deepens switching costs.
What does Collective's partnership with Qualtrics through GBK Collective reveal about its data and analytics strategy?
The Qualtrics partnership through GBK Collective — focused on real-time data and analytics methodologies for business intelligence and consumer experience measurement — signals that Collective is embedding itself into enterprise-grade research infrastructure rather than operating as a standalone boutique. Aligning with Qualtrics gives Collective access to enterprise distribution channels and lends credibility with large clients who already trust the Qualtrics ecosystem. This suggests a go-to-market posture that leans on platform adjacency rather than direct-sales competition with larger research technology vendors.
What does Recollective's roster of enterprise clients — Kantar, Mattel, Microsoft, Ecobee, Nikon — signal about the competitive tier Collective is targeting?
The presence of Microsoft, Kantar, and Mattel as clients of Recollective — a research technology partner in Collective's ecosystem — indicates the platform is operating at enterprise scale, not just serving SMBs or startups. Microsoft specifically uses Recollective's AI-powered platform to scale qualitative research in-house, which signals demand for research infrastructure that reduces dependence on outside agencies. For competitive analysts, this suggests Collective's adjacent partners are winning enterprise mandates that could feed referrals or co-sell opportunities back into Collective's own services.
How does Collective's competitive positioning differ from Klue and Dovetail, the two most direct-use-case competitors named in available intelligence?
Klue focuses on AI-automated competitive intelligence delivery to sales teams in real time — a go-to-market enablement use case — while Dovetail emphasizes structured market research analysis and competitor assessment templates. Collective, by contrast, is positioned as a human factors research and consultancy firm for healthcare and medical devices, making it a specialist services business rather than a SaaS tool. The three are largely non-overlapping in buyer profile: Klue and Dovetail target GTM and product teams at tech companies, while Collective targets R&D, regulatory, and product safety functions at medical device and pharma firms.
What does Collective's event participation pattern — life sciences conferences, healthcare usability events, independent research unconferences — signal about where it is investing in market presence?
Collective's event footprint spans life sciences industry conferences (Lab of the Future USA, Pistoia Alliance London) and community-oriented research gatherings (Mighty Mini Research Collective unconference), indicating a dual strategy: maintaining credibility with enterprise life sciences buyers while also cultivating the independent research and consultancy community. Sponsoring or attending events like the Pistoia Alliance conference — which focuses on data, automation, and innovation in life sciences — signals an intent to position alongside technology vendors serving pharma and biotech, not just as a traditional consultancy.
What does the absence of any documented M&A activity for Collective as of March 2026 suggest about its growth strategy?
With no acquisitions or mergers documented as of March 2026, Collective appears to be pursuing organic growth rather than an inorganic expansion strategy, despite having raised $121M in total funding. This could reflect a deliberate choice to deepen vertical expertise in medical device human factors rather than broaden scope through acquisition, or it may indicate that management has not yet identified compelling acquisition targets at acceptable valuations. For corp-dev teams evaluating Collective as an acquiree, the lack of M&A activity leaves the cap table relatively clean.
What does Collective's small team size of 21 employees relative to its ~$62.5M revenue imply about its operating model?
A 21-person team generating approximately $62.5M in annual revenue implies an unusually high revenue-per-employee figure — roughly $3M per head — which is atypical for a pure professional services firm and more consistent with a platform or hybrid model with some recurring, scalable revenue. This metric warrants scrutiny: either revenue includes pass-through or lab-rental components that inflate the top line relative to headcount, or the company has a software or subscription layer that ForesightIQ has not fully characterized. Either way, the ratio signals a capital-efficient operating model worth investigating in diligence.
What does Collective's positioning as a Contract Research Organization (CRO) alongside its consultancy work signal about its revenue model and client stickiness?
Offering CRO services — scientific services, clinical research, participant recruitment, and regulatory compliance — alongside traditional human factors consultancy means Collective embeds itself into clients' product development and regulatory submission workflows, which are high-stakes and time-sensitive. This creates meaningful switching costs: clients who rely on Collective for FDA-facing human factors validation are unlikely to change vendors mid-program. The CRO designation also opens doors to biotech and venture-backed medical device startups that need outsourced research infrastructure, broadening the client base beyond established manufacturers.
What does the leadership intelligence gap — no named executives at Collective itself documented in available sources — signal about the company's public profile and diligence risk?
The absence of named Collective executives in available intelligence — the leadership section surfaces only Disney and broader industry figures, not Collective-specific leadership — suggests the company maintains a deliberately low public profile, which is common for founder-led or private professional services firms of its size. For corp-dev and strategy teams, this creates a diligence gap: leadership tenure, founder equity concentration, and management depth are all unknowns that would need to be resolved through direct engagement or data providers like ForesightIQ that track private-company signals. Low visibility can also mean limited personal branding risk but harder benchmarking of management quality.
How does Collective's specialized pricing model compare to the broader research-tech competitive set, and what does that imply about deal structure if acquired?
The research-tech competitive set — Maze, Elicit, CB Insights, OpinionX — operates on tiered SaaS models ranging from free tiers to enterprise contracts, with Elicit estimated at $120–$780 per user per month depending on tier. Collective, as a human factors consultancy and CRO, likely prices on project retainers and lab utilization rather than per-seat SaaS subscriptions, meaning its revenue is more service-oriented and less predictable than software peers. In an acquisition context, this pricing structure would typically command a lower revenue multiple than pure SaaS, but the regulatory-embedded nature of its work and high revenue-per-employee could partially offset that discount.
Powered by ForesightIQ · Competitive intelligence from digital exhaust